Proximal Lower Limb Intramuscular Block : Effects on Hemiparetic Gait
NCT ID: NCT05519592
Last Updated: 2022-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2022-09-09
2023-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of the Femoral Nerve Block on Quadriceps Strength
NCT01111513
Determine the Main Muscle Participant in the Deformation of the Elbow in Hemiplegic Patients
NCT02455232
Adductor-Canal-Blockade Versus the Femoral Nerve Block Effect on Muscle Strength and Mobilization in Healthy Volunteers
NCT01449097
MED90 of Ropivacaine for Peripheral Nerve Block on Posture-evoked Pain in Spinal Anesthesia Positioning
NCT04705974
Adductor Canal Blockade vs Femoral Nerve Blockade on Muscle Strength, Mobility and Pain After TKA
NCT01922596
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
About gait, most of the litterature focuses on distal muscles targets. There are no studies about proxmial muscles role (gluteus maximus). Anesthesic perineural block have the disavantage to induce sensitive block as intramuscular block do not.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ropivacaine
Ropivacaine intramuscular injection
Ropivacaine injection
Intramuscular ropivacaine injection (gluteus maximus and rectus femoris)
Control
Sodium Chlorure intramuscular injection
Sodium Chloride Injection
Intramuscular sodium chloride injection (gluteus maximus and rectus femoris)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ropivacaine injection
Intramuscular ropivacaine injection (gluteus maximus and rectus femoris)
Sodium Chloride Injection
Intramuscular sodium chloride injection (gluteus maximus and rectus femoris)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* avoiding ground swing phase gait disorder
Exclusion Criteria
* INR \> 3.5
* local cutaneous affection on injection sites
* acute medical affection
* seizure
* hypersensitivity to anesthesics
* brugada syndrome
* porphyria
* severe cardiac disorder
* polyradiculopathy
* botulinum toxin injection \< 2 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Henri Mondor University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ETIENNE SAVARD
Hospital Practictioner
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A01457-36
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.